Table 4.
Tests | Method and interpretation |
---|---|
Screening tests | |
Double disk approximation or double disk synergy | Disk of third generation cephalosporin placed at 30 mm distance from amoxicillin-clavulanic acid. Enhanced inhibition indicates ESBL |
Combination disk | Uses two discs of third generation cephalosporin alone and combined with clavulanic acid. An increase in the zone inhibition of >5 mm with the combination disk indicates ESBL |
Microdilution test | Growth in a broth containing 1 μg/ml third generation cephalosporin indicates ESBL |
Confirmatory tests | |
MIC broth dilution | MIC of third generation cephalosporin alone or combined with clavulanic acid. A decrease in the MIC of the combination of ≥3 twofold dilutions indicates ESBL |
E test (MIC ESBL strips) | Two sided strip containing ceftazidime on one side and ceftazidime-clavulanic acid on the other. The ratio of the MIC of the combination to that of ceftazidime alone of >8, or the presence of a phantom zone (or both) indicates ESBL |
Automated instruments (for example, Vitek) | Measures MICs and compares growth of bacteria in presence of ceftazidime v ceftazidime-clavulanic acid |
Molecular (DNA probes, PCR, RFLP) | Targets specific nucleotide sequences to detect different variants of TEM and SHV genes |
ESBL=extended spectrum β lactamases; MIC=minimum inhibitory concentration; PCR=polymerase chain reaction; RFLP=restriction fragment length polymorphism.